Home
About
Company Profile
Culture
History
Honors
Products
Formulation Products
API & Intermediate
R&D
R&D Platform
Research Strength
Social Responsibility
Sustainable Development
Public Welfare Activity
News
Company News
Media Coverage
Notice
Contact
Cooperation Inquiry
Employee Style
Adverse Drug Reaction Reporting
Investor Relations
Announcement & Notice
Performance Report
Investor Communication
English
中文简体
Public welfare activity
Hunan Xianshi Pharmaceutical Co., Ltd. has donated an emergency rescue vehicle to the Yueyang Blue Sky Rescue Team, supporting the cause of public emergency response!
Hunan Xianshi Pharmaceutical Co., Ltd. has donated an emergency rescue vehicle to Yueyang Blue Sky Rescue Team to support local public emergency rescue initiatives.
→
View Details
11-13
2024
Xue Haipeng, Deputy General Manager of Hunan Xianshi Pharmaceutical Co., Ltd., and his delegation paid a visit to the university for a research tour.
On October 17–18, a delegation led by Xue Haipeng, Deputy General Manager of Hunan Xianshi Pharmaceutical Co., Ltd., and Luo Ming, Director of R&D, paid a visit to our institute for a fact-finding mission. The institute’s President Ai Weiping, together with Vice Presidents Hou Jihua and Qiao Xinjiang, received the delegation and held a symposium.
10-22
Hunan Xianshi Pharmaceutical Recognized as 2023 Changsha Municipal Enterprise Technology Center
CHANGSHA, Feb 18, 2024 — Hunan Xianshi Pharmaceutical Co., Ltd. has been officially accredited as a municipal-level Enterprise Technology Center under Changsha’s 2023 annual recognition program.
02-18
Pooling resources to tackle tough challenges! A wave of high-quality projects is set to be completed and put into operation.
As the autumn winds rise and the weather grows cooler, project construction has entered its prime phase. To accelerate project development and ensure early commissioning, on the morning of August 25, Zheng Yiren, Secretary of the Party Working Committee, led a team to conduct field visits to six projects—Zhong’an Bio, Weierman, Zhongnong Xilong, Runxing Pharmaceutical, Xianshi Pharmaceutical, and Zhongyi Gas. He emphasized that today’s projects will become tomorrow’s industries, and that time equates to efficiency. With the onset of cooler weather, all relevant functional departments must strengthen their support services, while each project entity, while prioritizing safe construction, should enhance coordination and expedite progress to ensure timely production and full operational effectiveness. Chen Xunwu, a member of the Party Working Committee and Deputy Director of the Management Committee, also participated in the inspection.
08-25
2023
An industrial policy, infused with deep passion for industry.
Changsha Evening News, Changsha in Hand, February 18 (All‑media reporter Wu Ling, correspondents Li Yanling and Zhou Ying): On the 16th, at the Liuyang Economic Development Zone’s conference on fully implementing the spirit of the 20th National Congress of the Communist Party of China, accelerating high‑quality development, and reviewing the 2023 economic work, four major policies benefiting enterprises were unveiled. Among them, the “Several Policies on Accelerating the High‑Quality Development of the Biopharmaceutical Industry” (hereinafter referred to as the “Several Policies”) marks the first time in the zone’s history that a comprehensive, systematic set of industrial support measures has been formulated for a single sector.
02-22